Ropivacaine Hydrochloride
NDC 17478-082
Product Information
Ropivacaine Hydrochloride is a ANDA-approved product labeled by Akorn. This product is primarily utilized in pharmaceutical processing or compounding. It is supplied as a product. This product entry covers the primary NDC 17478-082 and 2 associated package configurations. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Labeler & Regulatory Data
Marketing Timeline
Code Structure Chart
Product Details
What is NDC 17478-082?
What are the uses of this product?
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- ROPIVACAINE HYDROCHLORIDE (UNII: V910P86109)
- ROPIVACAINE (UNII: 7IO5LYA57N) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- SODIUM CHLORIDE (UNII: 451W47IQ8X)
- WATER (UNII: 059QF0KO0R)
- SODIUM HYDROXIDE (UNII: 55X04QC32I)
- HYDROCHLORIC ACID (UNII: QTT17582CB)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 1734347 - ROPivacaine HCl 0.2 % in 100 ML Injection
- RxCUI: 1734347 - 100 ML ropivacaine hydrochloride 2 MG/ML Injection
- RxCUI: 1734347 - ropivacaine HCl 0.2 % per 100 ML Injection
- RxCUI: 1734347 - ropivacaine HCl 200 MG per 100 ML Injection
- RxCUI: 1734355 - ROPivacaine HCl 0.2 % in 200 ML Injection
* Please review the full disclaimer at the bottom of this page.